CClinicalTrials.gg
Status unknownNCT04290234TEDDYUpdated Feb 28, 2020

Childhood Trauma and Escape Decision Dynamics

An observational study in Child Abuse and Fear, sponsored by University Hospital, Bonn. Status unknown at 1 site in Germany. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-02-28.

Sponsored by University Hospital, Bonn · Observational

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effects of childhood maltreatment on cognitive and reactive fear.

Read the detailed description

Childhood maltreatment dramatically increases the risk for psychiatric disorders accompanied by profound difficulties in social interactions. However, it is still unclear how childhood maltreatment affects social interactions in adulthood. In this study, we examine how childhood maltreatment may modulate threat sensitivity assessed by the distance at which an individual flees from an approaching threat. While rapid escape decisions rely on "reactive fear" circuits, slower escape decisions are associated with "cognitive fear" circuits. Based on previous observations of altered early sensory processing, we expect that childhood maltreatment affects both cognitive and reactive fear circuits.

02

Conditions studied

  • Child Abuse
  • Fear

Keywords

  • cognitive fear
  • fMRI
  • reactive fear
03

In context

Lead sponsor

University Hospital, Bonn is the lead sponsor of 154 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants will be recruited from a community sample and childhood maltreatment will be assessed with the Childhood Trauma Questionnaire.

Inclusion criteria

  • Healthy subjects with varying levels of childhood maltreatment

Exclusion criteria

Exclusion Criteria:

  • current psychiatric illness
  • current psychiatric medication or psychotherapy
  • MRI contraindication (e.g. metal in body, claustrophobia)
  • pregnancy
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Non-medicated healthy adults with childhood maltreatment

    The 25-item retrospective Childhood Trauma Questionnaire (CTQ) will be administered to assess history of abuse and neglect. The CTQ measures five types of maltreatment: emotional, physical, and sexual abuse and emotional and physical neglect.

    Other: fMRI assessment of cognitive and reactive fear

Interventions

  • OtherfMRI assessment of cognitive and reactive fear

    An fMRI paradigm will be used to probe how childhood maltreatment may modulate the defensive survival circuitry that facilitates escape decisions when subjects encounter fast- or slow-attacking threats.

06

What researchers measure

Primary outcomes

  1. Neural responses in the flight initiation distance (FID) task

    Functional magnetic resonance imaging (fMRI) will be performed to measure blood-oxygen-level dependent signal in a flight initiation distance (FID) task, involving fast-, medium- and slow-attacking virtual predators that elicit distinct activations in the reactive and cognitive fear circuits. Blood-oxygen-level-dependent signals to different predator velocities will be analyzed. Analyses will focus on regions-of-interest associated with the processing of cognitive fear (ventromedial prefrontal cortex, posterior cingulate cortex, hippocampus, and basolateral amygdala) and reactive fear (midbrain periaqueductal gray, central amygdala, hypothalamus, and the midcingulate cortex). To examine effects of childhood maltreatment, regression analyses with Childhood Trauma Questionnaire scores will be conducted on the second level.

    Time frame: fMRI paradigm with an average duration of 45 minutes

  2. Flight distance in the flight initiation distance (FID) task

    Associations between the flight distance in the FID task and childhood maltreatment will be analyzed using regression analyses with Childhood Trauma Questionnaire scores. Behavioral data will be correlated with fMRI data of the FID task.

    Time frame: fMRI paradigm with an average duration of 45 minutes

  3. Difficulty ratings in the flight initiation distance (FID) task

    Associations between the difficulty ratings in the FID task and childhood maltreatment will be analyzed using regression analyses with Childhood Trauma Questionnaire scores. Behavioral data will be correlated with fMRI data of the FID task.

    Time frame: fMRI paradigm with an average duration of 45 minutes

  4. Confidence ratings in the flight initiation distance (FID) task

    Associations between the confidence ratings in the FID task and childhood maltreatment will be analyzed using regression analyses with Childhood Trauma Questionnaire scores. Behavioral data will be correlated with fMRI data of the FID task.

    Time frame: fMRI paradigm with an average duration of 45 minutes

07

Study locations

1 of 1 sites recruiting
  • Department of Psychiatry, University of Bonn
    Bonn, 53105, Germany
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04290234
Lead sponsor
University Hospital, Bonn
Collaborators
Prof. Dean Mobbs
Responsible party
Rene Hurlemann (Professor for Psychiatry, University of Oldenburg) — Principal investigator
First posted
Feb 28, 2020
Start date
Nov 17, 2019
Primary completion
Jun 2020 (estimated)
Completion
Jun 2020 (estimated)
Last update
Feb 28, 2020

Study contacts

Dirk Scheele, PhD
Contact
Dirk.Scheele@ukbonn.de
+49-(0)228-287 ext. 11151
Dirk Scheele, PhD
principal investigator · University of Bonn

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion